Rock Springs Capital Management »

Pharvaris N V shares owned by Rock Springs Capital Management

Quarter-by-quarter ownership of Pharvaris N V (PHVS) shares owned by Rock Springs Capital Management from 13F filings

Historical chart of Rock Springs Capital Management investment in Pharvaris N V

Tip: Access up to 7 years of quarterly data

All positions including Pharvaris N V held by Rock Springs Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharvaris N V by Rock Springs Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $17M 753k 23.11

More positions owned by Rock Springs Capital Management

Blueprint Medicines (BPMC)
Immunocore Hldgs Ads (IMCR)
Neurocrine Biosciences (NBIX)
Evolent Health Cl A (EVH)
Intuitive Surgical Com New (ISRG)
UnitedHealth (UNH)
Penumbra (PEN)
IDEXX Laboratories (IDXX)
Acadia Healthcare (ACHC)
Argenx Se Sponsored Adr (ARGX)
Boston Scientific Corporation (BSX)
Ultragenyx Pharmaceutical (RARE)
Dex (DXCM)
Eli Lilly & Co. (LLY)
Freshpet (FRPT)

View all positions for Rock Springs Capital Management

Top funds holding Pharvaris N V

General Atlantic
FMR
venBio Partners
Foresite Capital Management IV
Viking Global Investors
VR Adviser
Bain Capital Life Sciences Investors
Commodore Capital
Cormorant Asset Management
Novo A/S
Deerfield Management Company
EcoR1 Capital
5AM Venture Management
T. Rowe Price Associates
Rock Springs Capital Management

View all funds holding Pharvaris N V